For participants in clinical trials, the answer is a hard no. The Trump administration's decision to end funding for the U.S.

Exploring Regulatory Affairs, the discipline dedicated to ensuring that new drugs and biologics are safe, effective, and ...

A local breast cancer survivor is hoping to break down barriers when it comes to increasing diversity in medical trials.

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

Clinical research is indeed a data beast. Healthcare organizations are practically drowning in patient information from their studies—everything from vitals to lab results to patient-reported outcomes ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Innovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.

This is due to a lack of data from large-scale clinical trials depicting the valuable effects of probiotics in improving ...